Asset Publisher

New study shows that Proprotein Convertase 6 plays a key role in vascular disease

New study shows that Proprotein Convertase 6 plays a key role in vascular disease

In a new study published in Circulation Research, researchers at CMM show that the enzyme PCSK6, the proprotein convert subtilisin / kexin 6, plays a key role in vascular disease. The findings give hope that PCSK6 may become a future target molecule for the development of anti-vascular disease drugs.

Unstable atherosclerosis causes myocardial infarction and stroke, but detailed knowledge is lacking about the molecular processes that make atherosclerotic plaques unstable. 

In a study from 2013 (Perisic L et al)1, researchers from the Vascular Surgery Group showed that PCSK6, proprotein convertase subtilisin/kexin 6 was one of the most enriched molecules in atherosclerotic plaques from patients with unstable atherosclerosis in the carotid artery.

In a new study published in Circulation Research (Rykaczewska U, Suur BE, Röhl S et al)2, the group has studied in detail the importance of PCSK6 in human vascular disease and demonstrated how this enzyme regulates the function of smooth muscle cells and structural remodelling of the vessel wall in various vascular diseases. The findings, which are based on several large patient cohorts, but also experimental cell culture studies and animal experiments, give hope that PCSK6 can become a future target molecule for the development of therapies for vascular disease. The latter can be seen in the light of the success of drugs against PCSK9, a related enzyme, which in recent years has been targeted for the treatment of high blood cholesterol and cardiovascular disease. The study was conducted in a broad international collaboration with over 5000 patients and was led by Professor Ulf Hedin and Assistant Professor Ljubica Matic

Read more about the study on Karolinska Institutets website here

 

 

1.

Profiling of atherosclerotic lesions by gene and tissue microarrays reveals PCSK6 as a novel protease in unstable carotid atherosclerosis, Perisic L et al., Arterioscl Thromb Vasc Biol. 2013, October; 33 (10): 2432-43

 

2. 

PCSK6 Is a Key Protease in the Control of Smooth Muscle Cell Function in Vascular Remodeling.Rykaczewska U, Suur BE, Röhl S et al., Circ Res 2020 Jan 2 doi:10.1161/CIRCRESAHA.119.316063

NEWS

CMMers on the 2020 Highly Cited List

CMMers on the 2020 Highly Cited List Clarivate, the company behind Web of Science, has published its 2020 list of highly cited researchers. Two of the thirteen researchers...

Swedish Cancer Society Grants

Swedish Cancer Society Grants From left to right: Fredrik Wermeling, Carmen Gerlach, Alexander Espinosa, Ning Xu Landén. Missing: Roland Nilsson. Photos: Private (Fredrik...

Grants from the Swedish Research Council

Grants from the Swedish Research Council We congratulate the CMMers who have recently received grants from the Swedish Research Council (Vetenskapsrådet).   Within the category of...

New Molecular Insights into Disease Exacerbation in Multiple Sclerosis

New Molecular Insights into Disease Exacerbation in Multiple Sclerosis Importance of the Atg7 gene for the recovery from inflammation in the central nervous system Multiple...

Grant from Forte to Xia Jiang

Grant from Forte to Xia Jiang Xia Jiang, Assistant Professor in Ingrid Kockum’s Group at CMM, is one of the 11 researchers from Karolinska Institutet who received research grants as a part...

Improved Patient Classification in Chronic Lymphocytic Leukemia

Improved Patient Classification in Chronic Lymphocytic Leukemia CMM Group Leader Professor Richard Rosenquist Brandell, is one of the main coauthors of a large study recently published in ...

Finding Molecular Links between Stress and Depression

Finding Molecular Links between Stress and Depression Vasco Sousa, researcher in Per Svenningson’s Group at CMM, is the first author of a study with the title “P11 deficiency increases...

Nanna Svartz Scholarship for Outstanding Research in Rheumatology 2020

Nanna Svartz Scholarship for Outstanding Research in Rheumatology 2020 The Nanna Svartz scholarship for outstanding research in rheumatology 2020 is awarded to Marie Wahren-Herlenius,...

Susanna Brauner Awarded the Swedish Society of Medicine's Translational Research Prize

Susanna Brauner Awarded the Swedish Society of Medicine's Translational Research Prize Susanna Brauner , Assistant professor and CMM researcher (Fredrik Piehl’s Team) has received the...

Ning Xu Landén 2020 Year’s Winner of the LEO Foundation Award

Ning Xu Landén 2020 Year’s Winner of the LEO Foundation Award Associate Professor Ning Xu Landén, Group Leader at CMM is the winner of this year’s LEO Foundation Award in Region EMEA...